Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01013480
Recruitment Status : Terminated (all active subjects rolled into 209FX303/NCT01013480)
First Posted : November 13, 2009
Last Update Posted : December 20, 2012
Sponsor:
Information provided by (Responsible Party):
Seaside Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2012
Actual Study Completion Date : December 2012